A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer Sun Jin SymHeung Moon ChangYoon-Koo Kang Original Article 21 February 2008 Pages: 1 - 8
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study Peter Mu-Hsin ChangPo-Min ChenMuh-Hwa Yang Original Article 15 March 2008 Pages: 9 - 17
Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model Michael J. KelnerTrevor C. McMorrisPharnuk Suthipinijtham Original Article 28 February 2008 Pages: 19 - 26
Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol Zengshuan MaOmmoleila MolaviAfsaneh Lavasanifar Original Article 20 February 2008 Pages: 27 - 35
Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism Benjamin D. BowlingNicole DoudicanSeth J. Orlow Original Article 23 February 2008 Pages: 37 - 43
In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells Amy HackerLaurence J. MartonRobert A. Casero Jr. Original Article 27 February 2008 Pages: 45 - 53
Does saturable formation of gemcitabine triphosphate occur in patients? Lai-San ThamLing-Zhi WangNicholas H. G. Holford Original Article 28 February 2008 Pages: 55 - 64
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies Laura Q. M. ChowDaniel L. GustafsonS. Gail Eckhardt Original Article 05 March 2008 Pages: 65 - 74
Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting Susumu NakadeTomoya OhnoYasuyuki Miyata Original Article 04 March 2008 Pages: 75 - 83
High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1 Hidekazu KuramochiKazuhiko HayashiMasakazu Yamamoto Original Article 29 February 2008 Pages: 85 - 89
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution Pedro M. G. SoaresJosé Maurício S. C. MotaMarcellus H. L. P. Souza Original Article 07 March 2008 Pages: 91 - 98
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors E. Claire DeesBert H. O’NeilRobert Z. Orlowski Original Article 08 March 2008 Pages: 99 - 107
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer Noelle K. LoConteJames P. ThomasJill Kolesar Original Article 06 March 2008 Pages: 109 - 115
Antitumor activity of noscapine in human non-small cell lung cancer xenograft model Tanise JacksonMahavir B. ChouguleMandip Singh Original Article 13 March 2008 Pages: 117 - 126
In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichloro-bis(pyrazole)platinum(II) complexes as anticancer agents Frankline K. KeterStonard KanyandaMervin Meyer Original Article 19 March 2008 Pages: 127 - 138
Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR positive advanced colorectal cancer treated with gefitinib? M. G. ZampinoE. MagniF. de Braud Original Article 08 March 2008 Pages: 139 - 148
Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study Virginia FerraresiMariangela CiccareseFrancesco Cognetti Original Article 20 March 2008 Pages: 149 - 155
Preclinical discovery of ixabepilone, a highly active antineoplastic agent Francis Y. F. LeeRobert BorzilleriGregory Vite Original Article Open access 18 March 2008 Pages: 157 - 166
Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma Xin LiuSui Yung ChanPaul Chi-Lui Ho Original Article 09 May 2008 Pages: 167 - 174
A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer Brian ChoiH. Ian RobinsMinesh Mehta Clinical Trial Report 28 February 2008 Pages: 175 - 179
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors Wells A. MessersmithAntonio JimenoManuel Hidalgo Clinical Trial Report 01 April 2008 Pages: 181 - 188
Response to taxanes in triple negative breast cancer Nilufer BulutSadettin KilickapKadri Altundag Letter to the Editor 04 March 2008 Pages: 189 - 189
